![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Glecaprevir/Pibrentasvir (G/P) and Ezetimibe for 8 Days Should Be the New Standard of Care With 100% Efficacy to Prevent Chronic HCV Infection in Non-liver Solid Organ Transplant (Sot) Recipients of HCV-VIREMIC Grafts
|
|
|
AASLD Nov 4-8 2022
Bashar A. Aqel, MD; Surakit Pungpapong,MD ; Adyr Moss,MD²; Kristen Ryland; Michael D Leise,MD; Rolland Dickson, MD.
Gastroenterology & Hepatology, Mayo Clinic Arizona, ²Transplant Surgery, Mayo Clinic Arizona
Transplantation, Mayo Clinic, Mayo Clinic Florida, Gastroenterology and Hepatology, Mayo Clinic Rochester
![1109221](../images/110922/110922-5/1109221.gif)
![1109222](../images/110922/110922-5/1109222.gif)
![1109223](../images/110922/110922-5/1109223.gif)
![1109224](../images/110922/110922-5/1109224.gif)
![1109225](../images/110922/110922-5/1109225.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|